InfoNet Logo

 New Mexico AIDS InfoNet

Fact Sheet Number 426

COMBIVIR


Eslabón a la Versión Español

 PrinterPrint

this Fact Sheet on a single page using:

 Microsoft Word

Adobe Acrobat

 More information on Downloading

& Printing Fact Sheets


WHAT IS COMBIVIR?

Combivir is a pill that contains two drugs used to fight HIV:

Retrovir (AZT) and Epivir

(3TC). Combivir is manufactured by GlaxoSmithKline.

The drugs in combivir are called nucleoside analog reverse

transcriptase inhibitors, or nukes. These drugs block the reverse

transcriptase enzyme. This enzyme changes HIV’s genetic material

(RNA) into the form of DNA. This has to occur before HIV’s genetic

code gets inserted into an infected cell’s own genetic codes.


WHO SHOULD TAKE

COMBIVIR?

Combivir was approved as an antiviral drug for people with HIV

infection. There are no absolute rules about when to start antiviral

drugs. You and your doctor should consider your T-cell

count, your viral load,

any symptoms you are having, and your attitude about taking HIV

medications. Fact Sheet 411

has more information about guidelines

for the use of antiviral medications.

If you take combivir with other antiviral drugs, you can reduce

your viral load to extremely low levels, and increase your T-cell

counts. This should mean staying healthier longer.

Children under 12 years old and people with kidney problems

should not take Combivir.

Combivir provides two drugs in one pill. It can be more convenient

to use combivir that some other combinations of drugs. This could

mean fewer missed doses and better control of HIV.


WHAT ABOUT DRUG

RESISTANCE?

Many new copies of HIV are mutations. They are slightly different

from the original virus. Some mutations can keep multiplying even

when you are taking an antiviral drug. When this happens, the

drug will stop working. This is called “developing resistance”

to the drug. See Fact Sheet 414

for more information on resistance.

Sometimes, if your virus develops resistance to one drug, it

will also have resistance to other antiviral drugs. This is called

“cross-resistance”.

Resistance can develop quickly. It is very important to

take antiviral medications according to instructions, on schedule,

and not to skip or reduce doses.


HOW IS COMBIVIR

TAKEN?

Combivir is taken by mouth as a tablet. The normal adult dose

is one tablet, two times a day. Each tablet includes 300 milligrams

(mg) of Retrovir (AZT) and 150 mg of Epivir (3TC).

Combivir can be taken with food, or between meals.

The dosage of 3TC should be reduced for people who weigh less

than 50 kilograms (110 pounds). People who weigh less than 110

pounds should normally not take Combivir.


WHAT ARE THE SIDE

EFFECTS?

When you start any antiviral treatment, you may have temporary

side effects such as headaches, high blood pressure, or a general

sense of feeling ill. These side effects usually get better or

disappear over time.

The most common side effects of combivir are the same as with

Retrovir (AZT) and Epivir (3TC). They include headache, upset

stomach, and fatigue. See Fact Sheet

551 for more information on fatigue.

The most serious side effects of AZT are anemia, granulocytopenia,

and myopathy. Very few people have these side effects. If they

occur, your doctor will probably have you stop using Combivir.

See Fact Sheet 420 on AZT for more

information on these side effects.

Anemia is a shortage of

red blood cells caused by damage to bone marrow. Fact

Sheet 552 has more information on anemia.

Granulocytopenia is a shortage of white blood cells

caused by damage to bone marrow.

Myopathy is muscle pain and weakness. There is no specific

treatment for myopathy.


HOW DOES COMBIVIR

REACT WITH OTHER DRUGS?

Combivir should not be taken with with ddC

(zalcitabine, Hivid®) or with d4T

(stavudine, Zerit®).

Blood levels of 3TC may be increased by bactrim

or septra. See Fact Sheet 535

for more information on these drugs.

AZT’s side effects may be worse if you are taking several other

drugs. Be sure your doctor knows about all the medications you

are taking.


Revised November 11, 2002

HomeGo

to InfoNet Main Page

Card FileGo to

Index of Fact Sheets

Question markClick

here if you have questions

The New Mexico AIDS InfoNet is a project of the

New Mexico AIDS Education and Training Center

Partially funded by the National Library of Medicine

and the New Mexico Department of Health